NTEC Insider Trading Activity and SEC Form 4 Filings
NTEC insider trading summary
No open-market insider purchases or sales of Intec Pharma Ltd. (NTEC) have been reported on SEC Form 4 in the past 12 months.
Latest NTEC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 4, 2020 | Dexcel Pharma Technologies Ltd. | 10% Owner | Sell | $32K (110,000 @ $0.29) |
| Feb 4, 2020 | Dan Oren | 10% Owner | Sell | $32K (110,000 @ $0.29) |
| Feb 3, 2020 | Dan Oren | 10% Owner | Sell | $25K (80,000 @ $0.32) |
| Feb 3, 2020 | Dexcel Pharma Technologies Ltd. | 10% Owner | Sell | $25K (80,000 @ $0.32) |
| Jan 31, 2020 | Dan Oren | 10% Owner | Sell | $224K (725,951 @ $0.31) |
| Jan 31, 2020 | Dexcel Pharma Technologies Ltd. | 10% Owner | Sell | $224K (725,951 @ $0.31) |
| Nov 19, 2019 | Issac Silberman | Director | Sell | $504 (1,000 @ $0.50) |
| Aug 28, 2019 | Jeffrey A Meckler | Chief Executive Officer | Buy | $14K (20,000 @ $0.68) |
| Aug 27, 2019 | Anthony J Maddaluna | Director | Buy | $12K (25,000 @ $0.47) |
| Aug 23, 2019 | Jeffrey A Meckler | Chief Executive Officer | Buy | $46K (100,000 @ $0.46) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.